| My Account | Subscribe | Contact Us | Donate |
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
If you are a physician, educator and medical professional who focus on the treatment of diabetes, then this is the must have resource for you.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
You can cancel your newsletter subscription at anytime by clicking "Unsubscribe" on the bottom of any newsletter you receive
Then enter your new email address in the above form and click "Subscribe"
Related Products Threads on Diabetes Health Forums
The Food and Drug Administration has given ARKRAY, Inc., a 510(k)* clearance to begin marketing its new GLUCOCARD® VitalTM blood glucose monitoring system in the United States.
1 comment - Nov 17, 2009 -
I recently ran into Theresa Garnero at the California AADE annual meeting and discovered that Diabetes Health had not yet reviewed her book, Your First Year with Diabetes: What To Do, Month By Month. We regret the oversight because it's a great resource for anyone dealing with the shock of a diabetes diagnosis. And Garnero is the perfect author for a book like this. She's an award-winning certified diabetes educator (CDE) and advanced practice registered nurse (APRN) with board certification in advanced diabetes management (BC-ADM), and she earned an Master of Science in Nursing (MSN). She is also a former national educator of the year, a cartoonist, and the 2008 global recipient of Inspired by Diabetes.
0 comments - Nov 6, 2009 -
Taking your child to the pediatrician for annual vaccinations is bad enough, but if your child requires daily injections, fingersticks, and infusion set changes, it can be traumatic over and over again. Thankfully, help is here! When a pediatrician by the name of Amy Baxter, MD, realized that kids were being told to "just deal with it" when it came to shots, she thought there had to be another way and came up with a nifty FDA-compliant device called a Buzzy.
0 comments - Oct 29, 2009 -
October 27, 2009 - Huntsville AL-Qualitest Pharmaceuticals today issued a voluntary nationwide recall of all Accusure® Insulin Syringes. The distributed syringes are of the following descriptions and NDC numbers: 28G 1/2cc, NDC 0603-6995-21;28G 1cc, NDC 0603-6996-21; 29G 1/2cc NDC 0603-6997-21, 29G 1cc, NDC 0603-6998-21, 30G 1/2cc, NDC 0603-999-21, 30G 1cc, NDC 0603-7000-21, 31G 1/2cc, NDC 0603-7001-21; and 31G 1cc, NDC 0603-7002-21. All Accusure® Insulin Syringes regardless of lot number are subject to this recall. These syringes were distributed between January 2002 and October 2009 to wholesale and retail pharmacies nationwide (including Puerto Rico). The syringes in these lots may have needles which detach from the syringe.
0 comments - Oct 29, 2009 -
LEXINGTON, Mass., October 27, 2009 - GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced data which support the safety and efficacy of the EndoBarrierTM Gastrointestinal Liner for pre-surgical weight loss treatment, along with a positive effect on glucose homeostasis in morbidly obese patients with type 2 diabetes mellitus. According to the study, mean excess weight loss (EWL) achieved after 12 weeks post implantation was 19.0 % for EndoBarrier patients versus 6.9 % for control patients (p<0.002). The results of this European weight loss study were published today in the advance online publication of Annals of Surgery.
2 comments - Oct 29, 2009 -
Montreal, Canada - 20 October 2009 - This October marks the one-year anniversary of the international launch of the ground-breaking diabetes Conversation MapTM education tools. Created by Healthy Interactions, a global leader in health education, in collaboration with the International Diabetes Federation (IDF), Eli Lilly and Company and other leading diabetes experts, the unique Conversation MapTM education tools have been implemented in 68 countries, excluding the United States, in 31 different languages in the last 365 days. To complete the global launch, redesigned diabetes Conversation MapTM education tools will be unveiled throughout Canada in January 2010, along with a new Map designed for parents and children to learn together. New tools will also be introduced to several Sub-Saharan African countries by early next year.
0 comments - Oct 29, 2009 -
The statistics are chilling. Children born today have a one-in-three chance of developing type 2 diabetes. For Latinos, however, that risk is one-in-two.
2 comments - Oct 27, 2009 -
Eurotech, an 84-year-old technology company, recently introduced its EverywareTM Medical Gateway, a remote monitoring device that it hopes will bolster the already notable effectiveness that home care diabetes monitoring has had in reducing hospital admissions. Along with several partners, including IBM and Roche, Eurotech demonstrated the device at the October Continua Health Alliance Fall Summit and Plugfest held in Boston.
1 comment - Oct 22, 2009 -
MSGI Security Solutions, which "serves the needs of counter-terrorism, public safety, law enforcement, and commercial security," has moved into a new area: diabetes detection. In fact, it has developed a handheld sensor that detects diabetes by measuring the level of acetone in the breath. The device, which employs carbon-based chemical sensors that detect organic vapors, is based upon nano sensors that NASA originally developed to make scientific measurements during space missions.
7 comments - Oct 9, 2009 -
For a while now, the Juvenile Diabetes Research Foundation (JDRF) has been conducting clinical trials on the effectiveness of continuous glucose monitoring (CGM) for people with type 1 diabetes. Last year, they issued their first two reports on their findings, showing that CGMs can improve control even for people who already have A1c's below 7%. That information has already had a powerful impact: It's convinced a number of large health insurers (including Aetna, Cigna, Kaiser Permanente, United Healthcare, and Wellpoint) to cover CGMs for type 1s, and it's led to the inclusion of CGMs in national standards of care for type 1 diabetes.
3 comments - Sep 17, 2009 -